evolcSign inStart free
Menu

Oxsonics

Clinical-stage drug delivery company developing SonoTran, an ultrasound platform that boosts anti-cancer drug penetration into solid tumours

Oxford, United KingdomFounded 2013oxsonics.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-31

About Oxsonics

OxSonics develops SonoTran®, an ultrasound-based platform designed to enhance the delivery of oncology drugs into solid tumours. The platform is drug agnostic and does not require drug reformulation, and the company states it is under clinical evaluation.

The company develops its own programmes and collaborates with pharmaceutical and biotech companies on anti-cancer therapies. Its stated focus is on solid tumours that cannot be surgically removed or treated with radiotherapy.

OxSonics was founded in 2013 to commercialise technology developed at the Biomedical Ultrasonics, Biotherapy and Biopharmaceuticals Laboratory (BUBBL) at the University of Oxford. Its headquarters are in Oxford, UK, and its team is based on the Oxford Science Park.

Product: SonoTran® ultrasound-based platform that enhances delivery of oncology drugs into solid tumours.

Jobs at Oxsonics

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Pathios Therapeutics

    Develops GPR65-targeting cancer immunotherapies for patients with solid tumors
    Abingdon, United KingdomBiotech & pharmaFounded 2017
    New on Evolc

  • Peptone

    Drug discovery platform designing small-molecule candidates for hard-to-treat cancers and neurodegenerative disease targets
    Mansfield, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

  • Petagene

    Genomic data compression, cloud access and encryption software for genomics researchers and bioinformatics teams
    Cambridge, United KingdomBiotech & pharmaFounded 20161 open job
    New on Evolc

  • Pheno Therapeutics

    Develops GPR17-targeting neuroprotective therapeutics for patients with multiple sclerosis and other neurological disorders
    Edinburgh, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

  • Phoremost

    Biotech developing oral small-molecule cancer drugs, lead programme PMC-001 for primary and metastatic brain cancers
    Cambridge, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Phynova Group

    Develops plant-derived health ingredients, including Reducose for blood glucose, for supplement, food and beverage makers
    Banbury, United KingdomBiotech & pharmaFounded 2004
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • Google Analytics 4
  • WordPress
  • nginx